NURS 3110 Heart Failure Pharmacology 2026 – 20+ Cardiac Drug Exam Questions and Answers | Digoxin, Entresto, Milrinone & SGLT2 Inhibitors Review | Chamberlain University Nursing

This comprehensive NURS 3110 pharmacology study guide contains more than 20 exam-focused questions and answers covering heart failure medications, cardiac glycosides, phosphodiesterase inhibitors, and modern pharmacologic therapies used in the management of cardiovascular disease and chronic heart failure. The document is specifically designed for nursing students preparing for pharmacology exams, ATI assessments, cardiovascular nursing tests, NCLEX-RN review, and medication administration competency evaluations. It provides a concise yet high-yield review of medication mechanisms of action, therapeutic uses, adverse effects, toxicity risks, and critical nursing considerations related to heart failure pharmacotherapy. Key cardiovascular pharmacology topics covered include cardiac glycosides, dysrhythmia risks associated with digoxin therapy, phosphodiesterase inhibitors, phosphodiesterase IV inhibitors, angiotensin receptor-neprilysin inhibitors (ARNIs), and sodium-glucose cotransporter-2 (SGLT2) inhibitors. Major medications discussed throughout the document include digoxin, valsartan (Entresto component), milrinone, sildenafil, vardenafil, tadalafil, and dapagliflozin. The guide also reviews myocardial contractility enhancement, cardiac output improvement, AV block complications, digoxin toxicity, CNS adverse effects, hypotension risks, visual disturbances, arrhythmia monitoring, gastrointestinal side effects, and pharmacologic management strategies for heart failure patients. This resource is highly beneficial for BSN students, ADN nursing students, practical nursing (LPN/LVN) students, pharmacology students, cardiovascular nursing learners, telemetry nurses, critical care nursing students, and healthcare trainees seeking to strengthen their understanding of heart failure pharmacology and safe cardiac medication administration. It is also valuable for ATI remediation, NCLEX cardiovascular pharmacology review, med-surg nursing preparation, cardiac clinical rotations, and rapid exam revision before nursing competency assessments. The heart failure pharmacology principles and cardiovascular medication guidelines referenced in this document align with evidence-based nursing and clinical practice resources, including: ATI Nursing Education – Cardiovascular and Pharmacology Review Modules Lehne’s Pharmacology for Nursing Care by Jacqueline Rosenjack Burchum & Laura Rosenthal Kee, Hayes & McCuistion’s Pharmacology: A Nursing Process Approach Brunner & Suddarth’s Textbook of Medical-Surgical Nursing Lewis’s Medical-Surgical Nursing: Assessment and Management of Clinical Problems American Heart Association (AHA) and American College of Cardiology (ACC) heart failure management guidelines National Council of State Boards of Nursing (NCSBN) NCLEX-RN Test Plan standards for pharmacological and parenteral therapies. Keywords NURS 3110 pharmacology, heart failure medications, cardiac glycosides nursing, digoxin pharmacology, digoxin toxicity nursing, cardiovascular pharmacology, ATI pharmacology exam, NCLEX heart failure review, dysrhythmia medication review, Entresto nursing considerations, valsartan pharmacology, milrinone nursing review, phosphodiesterase inhibitors, phosphodiesterase IV inhibitors, sildenafil nursing considerations, tadalafil adverse effects, dapagliflozin SGLT2 inhibitor, heart failure drug therapy, cardiac output medications, AV block nursing review, arrhythmia risk medications, heart failure nursing study guide, cardiovascular medication administration, med surg pharmacology review, nursing exam questions and answers, telemetry nursing pharmacology, cardiac medication side effects, ATI cardiovascular system, nursing pharmacology practice questions, cardiac drugs review